Phase 3 testing of the COVID-19 vaccine, developed by a German biotechnology company, will take place in Turkey and the United States.
According to Qadin.Net referring to publika.az, health workers will also participate in the tests as volunteers. The Turkish Ministry of Health will conduct the tests in 9 centers of universities and city hospitals. The process will start on September 10 and will be completed by the end of September.
The Ministry of Health will get the preliminary results by the end of November after testing the vaccine on healthy and volunteers of different age groups. Blood samples will be taken from 1,000 vaccinated volunteers at regular intervals to check for antibodies to the virus. It should be noted that 7,000 people took part in the first two stages of vaccination.